Genomic Valley Biotech Share Price | Genomic Valley Biotech Stock Screener
GVBL
Biotechnology
Share Price BSE
₹24.25
▼
-1.25 (-4.90%)
As of May 19, 2026, the Genomic Valley Biotech share price (BSE: GVBL) is ₹24.25, down 4.90% from the previous close, with shares trading between ₹24.23 and ₹24.25, and a 52-week range of ₹21.85–₹54.20.
Check GVBL annual price range for the annual price range and momentum.
Use the Genomic Valley Biotech stock screener below to analyse P/E ratio, market cap, quarterly results, and more. Record your trades in TickJournal's free trading journal and track your portfolio performance.
Genomic Valley Biotech Market Cap
₹8.11 Cr.
GVBL P/E Ratio (TTM)
-176.53
Genomic Valley Biotech P/B Ratio
2.06
EPS (TTM)
₹1.17
Dividend Yield
-
Debt to Equity
-
GVBL 52 Week High
₹54.20
Genomic Valley Biotech 52 Week Low
₹21.85
Operating Margin
13.00%
Profit Margin
-
GVBL Revenue (TTM)
₹1.00
EBITDA
-
Net Income
-
Total Assets
₹4.00
Total Equity
₹4.00
Genomic Valley Biotech Share Price Chart
Screen Genomic Valley Biotech share price with an interactive chart. Analyse GVBL price trends and volatility across different timeframes.
Genomic Valley Biotech Company Profile - Fundamental Screener
Screen Genomic Valley Biotech company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for GVBL shares.
Sector
Healthcare
Industry
Biotechnology
Sub-Sector
Biotechnology
Segment
E
ISIN
INE574D01010
Genomic Valley Biotech Balance Sheet Screener
Screen GVBL balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Total Assets | 4 | 4 | 4 | 4 | 8 | 8 | 7 | 7 | 6 | 6 |
| Current Assets | 3 | 3 | 3 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Fixed Assets | 0 | 0 | 0 | 2 | 6 | 5 | 4 | 4 | 4 | 3 |
| Liabilities | ||||||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 0 | 0 | 0 | 1 | 2 | 2 | 2 | 1 | 1 | 1 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | ||||||||||
| Total Equity | 4 | 4 | 4 | 3 | 5 | 5 | 5 | 5 | 5 | 5 |
| Share Capital | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
| Reserves & Surplus | 1 | 1 | 1 | 0 | 1 | 2 | 2 | 2 | 1 | 2 |
Genomic Valley Biotech Income Statement Screener - Profit & Revenue Analysis
Screen Genomic Valley Biotech income statement and profit fundamentals.
Analyze GVBL quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Genomic Valley Biotech share price evaluation.
| Item | None-None | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March | 2015-March |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1 | 1 | 0 | 3 | 0 | 0 | 1 | 1 | 1 | 1 | 0 | 0 |
| Expenses | 1 | 0 | 0 | 2 | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 0 |
| EBITDA | 0 | 0 | 0 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 |
| Operating Profit % | 13.00% | 52.00% | 9.00% | 32.00% | -535.00% | -66.00% | 65.00% | 42.00% | 17.00% | -23.00% | -422.00% | -249.00% |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit Before Tax | 0 | 0 | 0 | 1 | 0 | -1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 0 | 0 | 0 | 1 | 0 | -1 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS | -0.20 | 1.17 | 0.05 | 2.12 | -0.03 | -1.83 | 0.94 | 0.76 | 0.11 | -0.22 | -1.10 | -0.03 |
Genomic Valley Biotech Cash Flow Screener - Liquidity Fundamentals
Screen GVBL cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March | 2018-March | 2017-March | 2016-March |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | 0 | 0 | -1 | -2 | 2 | 0 | -1 | 1 | 0 | -1 |
| Investing Activities | 0 | 0 | 2 | 4 | -2 | -1 | 0 | -1 | 0 | 1 |
| Financing Activities | 0 | 0 | -1 | -2 | 0 | 0 | 1 | 0 | 0 | 0 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Genomic Valley Biotech Shareholding Pattern Screener
See Genomic Valley Biotech shareholding pattern with promoter, FII, and DII holdings.
Check Genomic Valley Biotech promoter holding and ownership changes for GVBL on TickJournal.
| Item | 2026-Mar | 2025-Mar | 2025-Jun | 2025-Sept | 2025-Dec | 2024-Mar | 2024-Jun | 2024-Sept |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 46.06% | 46.78% | 46.72% | 46.72% | 46.06% | 64.20% | 64.14% | 54.67% |
| FII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| DII Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 51.01% | 52.62% | 52.79% | 52.53% | 52.25% | 34.45% | 35.06% | 44.74% |
| Other Holding | 2.93% | 0.60% | 0.49% | 0.76% | 1.69% | 1.35% | 0.81% | 0.59% |
| Shareholder Count | 2,481 | 2,504 | 2,460 | 2,459 | 2,522 | 1,334 | 1,540 | 2,128 |
Genomic Valley Biotech Share Dividend Screener - Share Yield Analysis
Check Genomic Valley Biotech dividend history with payout and yield data.
View Genomic Valley Biotech dividend details including ex-dates and amounts for GVBL stock.
Genomic Valley Biotech Stock Index Membership
See which indices include Genomic Valley Biotech stock.
Check GVBL index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
Genomic Valley Biotech Market Events Screener - Corporate Actions
Get Genomic Valley Biotech corporate actions including splits, bonuses, and buybacks.
Check Genomic Valley Biotech stock events that may affect GVBL share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| 2026-12-31 | 2026-12-31 | Annual General Meeting | NA | -10.30% |
| 2026-01-15 | 2026-01-15 | Quarterly Result Announcement | NA | -5.10% |
| 2025-12-30 | 2025-12-30 | Annual General Meeting | NA | -18.30% |
| 2025-10-15 | 2025-10-15 | Quarterly Result Announcement | NA | 0.19% |
| 2025-08-07 | 2025-08-07 | Quarterly Result Announcement | NA | -2.15% |
| 2025-05-30 | 2025-05-30 | Quarterly Result Announcement | NA | -11.44% |
| 2025-02-14 | 2025-02-14 | Quarterly Result Announcement | NA | 14.40% |
| 2024-10-07 | 2024-10-07 | Quarterly Result Announcement | NA | 0.12% |
Genomic Valley Biotech Competitors Screener - Peer Comparison
Screen GVBL competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Anthem Biosciences | 43,999 | 94.84 | 1,930 | 30.15% | 451 | 59.14 |
| Advanced Enzyme Tech | 4,071 | 23.55 | 746 | 11.31% | 176 | 64.84 |
| CCME Global | 529 | -2338.00 | 4 | % | 0 | 20.27 |
| Vivo Bio Tech | 62 | 13.64 | 52 | 13.19% | 7 | 52.71 |
| Shree Ganesh Bio-Tech | 25 | -60.00 | 24 | 14.55% | 0 | 53.51 |
| Genomic Valley Biotech | 8 | -176.53 | 1 | 300.00% | 0 | 53.98 |
Genomic Valley Biotech Company Announcements - News Screener
Screen GVBL latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-04-14 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-04-03 | Disclosure Under Regulation 31(4) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulation 2011 | - |
| 2026-04-01 | Disclosure Under Regulation 31(4) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulation 2011 | - |
| 2026-03-24 | Closure of Trading Window | - |
| 2026-01-17 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-01-15 | Announcement under Regulation 30 (LODR)-Cessation | - |
| 2026-01-15 | Financial Results For The Quarter And Nine Month Ended 31St December 2025 | - |
| 2026-01-15 | Board Meeting Outcome for Outcome Of The Board Meeting Dated 15-01-2026 | - |
| 2026-01-06 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-01-03 | Board Meeting Intimation for Board Meeting Under Regulation 29 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015 | - |
| 2026-01-01 | Shareholder Meeting / Postal Ballot-Scrutinizers Report | - |
| 2025-12-31 | Shareholder Meeting / Postal Ballot-Outcome of AGM | - |
| 2025-12-29 | Closure of Trading Window | - |
| 2025-12-10 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2025-12-09 | Notice Of The Annual General Meeting | - |
| 2025-12-09 | Reg. 34 (1) Annual Report. | - |
| 2025-12-08 | Book Closure Intimation | - |
| 2025-12-08 | Board Meeting Outcome for Outcome Of The Board Meeting Dated 08-12-2025 | - |
| 2025-10-17 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2025-10-15 | Un-Audited Standalone Financial Results For The Quarter And Half Yearly Ended On September 30Th 2025 | - |